Surgery Websites
Resident Portal »  Resident Research Fellows »  Alexa Glencer, M.D.
Alexa Glencer, M.D.

Alexa Glencer, M.D.

Resident Research Fellow
General Surgery

Contact Information

Open Popup

Princeton University - Bachelor's Degree - 2010
University of California San Francisco - Doctor of Medicine - 2016

  • University of California San Francisco Medical Center - General Surgery Intern - 2016-2017
  • University of California San Francisco Medical Center - General Surgery Resident - 2017-present
  • Surgical oncology
  • Hepatobiliary and pancreatic surgery
  • Pancreatic IPMN organoid models of pancreatic cancer
  • Tumor immune microenvironment of DCIS

Alexa Glencer, M.D. is a General Surgery Resident in the UCSF Department of Surgery. Dr. Glencer attended Princeton University as an undergraduate, where she graduated magna cum laude with a major in biology and minors in global health & health policy and environmental science. She then moved to San Francisco, where she worked as a clinical trial coordinator in breast oncology at UCSF before attending medical school. She completed medical school at UCSF, during which time she continued to contribute to breast oncology clinical trial research. She is currently conducting research with Dr. Laura Esserman and Dr. Kim Kirkwood focused on characterizing the tumor immune microenvironment of breast ductal carcinoma in situ (DCIS) and pancreatic intraductal papillary mucinous neoplasms (IPMN). She is also working to develop a novel pancreatic cancer organoid model that she hopes will provide a strong physiologic correlate to the human tumor immune microenvironment.

  • T32 in GI Surgery
Data provided by UCSF Profiles, powered by CTSI
  1. Esserman LJ, Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR. The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment. Cancer Epidemiol Biomarkers Prev. 2020 Oct 08. View in PubMed
  2. Braun HJ, Dodge JL, Grab JD, Schwab ME, Liu IH, Glencer AC, Stock PG, Hirose R, Roberts JP, Ascher NL. Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization. Transplantation. 2020 May 18. View in PubMed
  3. Keck S, Glencer AC, Rugo HS. Everolimus and its role in hormone-resistant and trastuzumab-resistant metastatic breast cancer. Future Oncol. 2012 Nov; 8(11):1383-96. View in PubMed
  4. Rugo HS, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN. A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer. Breast Cancer Res Treat. 2012 Jul; 134(1):13-20. View in PubMed

 

Site Directory
    X